Galectin Therapeutics reported $143.6M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
Immunic USD 64M 23M Dec/2025
Incyte USD 18.73B 660M Mar/2026
Merck USD 297.1B 35.84B Mar/2026